Health Sciences Acquisitions Corporation 2
40 10th Avenue, Floor 7
New York, NY 10014

 

July 30, 2020

 

 

 

VIA EDGAR & TELECOPY
Mr. Ronald Alper
Division of Corporation Finance

Office of Real Estate & Construction
U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549 

 

RE:	Health Sciences Acquisitions Corporation 2 (the “Company”) Registration Statement on Form S-1 (File No. 333-239922) (the “Registration Statement”)

Dear Mr. Alper:

The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:30 p.m. on August 3, 2020, or as soon thereafter as practicable.

The Company hereby acknowledges that:

·

Should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

·

The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

·

The Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

[Signature page follows]

 

 

	Very truly yours,
	HEALTH SCIENCES ACQUISITIONS CORPORATION 2
	By:	/s/ Roderick Wong
		Name: Roderick Wong
		Title: Chairman and Chief Executive Officer